Oncotelic CEO Vuong Trieu to Present Innovative “Deciparticles” Platform at IDDST-Europe 2025 Conference in Stockholm
AGOURA HILLS, Calif., April 22, 2025 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB:OTLC), a biotechnology company focused on nanomedicine and…